PT3133396T - TREATMENT METHODS USING AMMONIA-CLEANING DRUGS - Google Patents
TREATMENT METHODS USING AMMONIA-CLEANING DRUGSInfo
- Publication number
- PT3133396T PT3133396T PT16176456T PT16176456T PT3133396T PT 3133396 T PT3133396 T PT 3133396T PT 16176456 T PT16176456 T PT 16176456T PT 16176456 T PT16176456 T PT 16176456T PT 3133396 T PT3133396 T PT 3133396T
- Authority
- PT
- Portugal
- Prior art keywords
- ammonia
- treatment methods
- drugs
- cleaning
- cleaning drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9323408P | 2008-08-29 | 2008-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3133396T true PT3133396T (en) | 2018-12-07 |
Family
ID=45604478
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97392633T PT2330892T (en) | 2008-08-29 | 2009-01-07 | METHODS OF TREATMENT USING AMMONIA ELIMINATING DRUGS |
| PT16176456T PT3133396T (en) | 2008-08-29 | 2009-01-07 | TREATMENT METHODS USING AMMONIA-CLEANING DRUGS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97392633T PT2330892T (en) | 2008-08-29 | 2009-01-07 | METHODS OF TREATMENT USING AMMONIA ELIMINATING DRUGS |
Country Status (10)
| Country | Link |
|---|---|
| JP (3) | JP5577341B2 (en) |
| DK (1) | DK3133396T3 (en) |
| ES (2) | ES2593378T3 (en) |
| HR (2) | HRP20161222T1 (en) |
| HU (2) | HUE029912T2 (en) |
| LT (2) | LT3133396T (en) |
| PL (1) | PL2330892T3 (en) |
| PT (2) | PT2330892T (en) |
| SI (1) | SI3133396T1 (en) |
| TR (1) | TR201816616T4 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2760479T1 (en) | 2011-09-30 | 2017-07-31 | Horizon Therapeutics, Llc | Nitrogen scavenging drug for use in a method of treating a nitrogen retention disorder |
| KR102264579B1 (en) * | 2012-04-20 | 2021-06-11 | 임메디카 파마 에이비 | Methods of therapeutic monitoring of phenylacetic acid prodrugs |
| PT2922576T (en) * | 2012-11-21 | 2018-01-24 | Horizon Therapeutics Llc | METHODS OF ADMINISTRATION AND EVALUATION OF DRUGS OF NITROGEN FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY |
| US9914692B2 (en) | 2016-05-25 | 2018-03-13 | Horizon Therapeutics, Llc | Procedure for the preparation of 4-phenyl butyrate and uses thereof |
| US10668040B2 (en) | 2017-09-11 | 2020-06-02 | Horizon Therapeutics, Llc | Treatment of urea cycle disorders in neonates and infants |
| JP6797456B2 (en) * | 2018-10-04 | 2020-12-09 | アトナープ株式会社 | Biological information acquisition system, health management server and system |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284647A (en) * | 1980-03-31 | 1981-08-18 | The Johns Hopkins University | Process for waste nitrogen removal |
| EP0858441B1 (en) * | 1995-02-07 | 2001-05-09 | Brusilow Enterprises, LLC | Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders |
| US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
-
2009
- 2009-01-07 LT LTEP16176456.8T patent/LT3133396T/en unknown
- 2009-01-07 SI SI200931886T patent/SI3133396T1/en unknown
- 2009-01-07 LT LTEP09739263.3T patent/LT2330892T/en unknown
- 2009-01-07 ES ES09739263.3T patent/ES2593378T3/en active Active
- 2009-01-07 PT PT97392633T patent/PT2330892T/en unknown
- 2009-01-07 PT PT16176456T patent/PT3133396T/en unknown
- 2009-01-07 PL PL09739263T patent/PL2330892T3/en unknown
- 2009-01-07 HU HUE09739263A patent/HUE029912T2/en unknown
- 2009-01-07 HR HRP20161222TT patent/HRP20161222T1/en unknown
- 2009-01-07 HU HUE16176456A patent/HUE040503T2/en unknown
- 2009-01-07 ES ES16176456T patent/ES2695534T3/en active Active
- 2009-01-07 JP JP2011525021A patent/JP5577341B2/en active Active
- 2009-01-07 TR TR2018/16616T patent/TR201816616T4/en unknown
- 2009-01-07 DK DK16176456.8T patent/DK3133396T3/en active
- 2009-08-27 JP JP2011525214A patent/JP2012501451A/en not_active Withdrawn
-
2014
- 2014-01-07 JP JP2014000920A patent/JP2014102255A/en not_active Withdrawn
-
2018
- 2018-11-08 HR HRP20181877TT patent/HRP20181877T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014102255A (en) | 2014-06-05 |
| DK3133396T3 (en) | 2018-12-03 |
| LT2330892T (en) | 2016-11-25 |
| SI3133396T1 (en) | 2018-12-31 |
| PT2330892T (en) | 2016-09-05 |
| JP2012501451A (en) | 2012-01-19 |
| JP2012501329A (en) | 2012-01-19 |
| JP5577341B2 (en) | 2014-08-20 |
| HUE029912T2 (en) | 2017-03-28 |
| HRP20161222T1 (en) | 2017-02-10 |
| ES2695534T3 (en) | 2019-01-08 |
| LT3133396T (en) | 2018-11-26 |
| HUE040503T2 (en) | 2019-03-28 |
| HRP20181877T1 (en) | 2019-01-11 |
| PL2330892T3 (en) | 2017-05-31 |
| ES2593378T3 (en) | 2016-12-09 |
| TR201816616T4 (en) | 2018-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2016053I1 (en) | TREATMENT METHODS USING AMMONIA-TRACKING PHARMACEUTICAL SUBSTANCES | |
| BRPI0910854A2 (en) | treatment methods | |
| IT1391555B1 (en) | EXTRACORPOREO BLOOD TREATMENT SYSTEM | |
| BRPI0914294A2 (en) | capsule treatment apparatus | |
| BRPI0910259A2 (en) | inflammation treatment methods | |
| EP2296593A4 (en) | MEDICAL COIFFE | |
| BRPI0919748A2 (en) | treatment device | |
| BRPI0914841A2 (en) | massage apparatus | |
| EP2351511A4 (en) | CAPSUED MEDICAL DEVICE | |
| PL2452709T3 (en) | CANNULA | |
| BRPI0907135A2 (en) | Chronic Pain Treatment Processes | |
| EP2327448A4 (en) | DEFIBRILLATION CATHETER | |
| BRPI0920521A2 (en) | pharmaceutical combination | |
| EP2320045A4 (en) | EXHAUST TREATMENT UNIT | |
| BRPI0920514A2 (en) | drug infusion | |
| EP3431138C0 (en) | BRAIN STIMULATION | |
| BRPI0917575A2 (en) | thalassemia treatment methods | |
| BRPI0917567A2 (en) | respiratory disease treatment | |
| EP2435825A4 (en) | DISEASE TREATMENT METHOD | |
| BRPI0915822A2 (en) | medical device | |
| DK2173831T3 (en) | WELL TREATMENT | |
| BRPI0917684A2 (en) | homeopathic therapeutic method | |
| DK3150178T3 (en) | Stimulation device | |
| HRP20181877T1 (en) | Methods of treatment using ammonia-scavenging drugs | |
| HRP20160577T1 (en) | OSTEOARTRITIS TREATMENT |